{"name": "Cartela AB",
 "permalink": "cartela-ab",
 "crunchbase_url": "http://www.crunchbase.com/company/cartela-ab",
 "homepage_url": "http://www.cartela.se",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cartela.se",
 "phone_number": "+460462221550",
 "description": "",
 "created_at": "Tue Sep 22 01:30:19 UTC 2009",
 "updated_at": "Thu Apr 29 03:22:18 UTC 2010",
 "overview": "\u003Cp\u003ECartela AB is a company principally engaged in research and development within the field of integrin research. Our main focus is centred on two collagen-binding integrins, alpha 10 and alpha 11, present on the cell surface of connective tissue cells.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.67M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 2670000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 4,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Volito",
         "permalink": "volito",
         "image":
          {"available_sizes":
            [[[92,
               84],
              "assets/images/resized/0008/5267/85267v1-max-150x150.jpg"],
             [[92,
               84],
              "assets/images/resized/0008/5267/85267v1-max-250x250.jpg"],
             [[92,
               84],
              "assets/images/resized/0008/5267/85267v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Industrifonden",
         "permalink": "industrifonden",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0003/2833/32833v1-max-150x150.png"],
             [[241,
               44],
              "assets/images/resized/0003/2833/32833v1-max-250x250.png"],
             [[241,
               44],
              "assets/images/resized/0003/2833/32833v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 616000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "",
   "source_description": "Cap Funding Report",
   "acquired_year": 2008,
   "acquired_month": 1,
   "acquired_day": 15,
   "acquiring_company":
    {"name": "Hansa Medical",
     "permalink": "hansa-medical",
     "image":
      {"available_sizes":
        [[[150,
           34],
          "assets/images/resized/0006/0400/60400v1-max-150x150.png"],
         [[250,
           56],
          "assets/images/resized/0006/0400/60400v1-max-250x250.png"],
         [[450,
           102],
          "assets/images/resized/0006/0400/60400v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "  S\u00c3\u00b6lvegatan 19   Biomedical Center I:12",
    "address2": "",
    "zip_code": " 22184 ",
    "city": "Lund",
    "state_code": null,
    "country_code": "SWE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}